Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC reiterated their hold rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a report published on Wednesday, MarketBeat Ratings reports. A number of other research analysts have also recently issued reports on SRDX. Barrington Research reaffirmed an outperform rating and issued a $71.00 price target on shares of Surmodics in […]
/PRNewswire/ -- The "In Vitro Diagnostics (IVD) Analyzers: Global Market" report has been added to ResearchAndMarkets.com's offering. The global market for IVD...
As per the report by Fortune Business Insights, the Infectious Disease Point-of-care (POC) Diagnostics Market size is projected to reach USD 12.46 billion...
StockNews.com upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a research report report published on Thursday. Several other equities analysts have also recently issued reports on the stock. Barrington Research boosted their target price on shares of Surmodics from $69.00 to $71.00 and gave the company […]
/PRNewswire/ -- The global in vitro diagnostics (IVD) market size is estimated to reach around USD 124.65 billion by 2032, increasing from USD 107.76 billion...